Employers search
Details
Tech Stack:
About Us
A pioneer in the web3 sector, Molecule aims to increase accessibility to biopharma research and development. They have developed a decentralized biotech platform that functions as a marketplace for intellectual property (IP) about research. This approach aims to swiftly and effectively match financing opportunities with researchers and biotech entrepreneurs. Molecule's ecosystem facilitates a community-driven approach, allowing patients, researchers, and investors to directly govern and own research-related IP through a scalable framework for biotech DAOs (Decentralized Autonomous Organizations). The company also focuses on empowering science with a human impact, propelling scientific discoveries from the lab to real-life applications. Molecule addresses the common issue of early-stage research often failing to progress due to insufficient expertise and funding. They offer a technology platform that sources ideas, capital, and know-how in real time on a global scale. Molecule gives scientists access to funding and the possibility of developing scientific discoveries; on the other hand, funders may help spur innovation and guarantee that scientific discoveries are available to everyone. With over $30 million in money within its ecosystem, Molecule has already invested $1.95 million in various projects. The community supporting Molecule includes more than 15,700 members, and 12 research projects have been successfully funded.